Arkolith/Insider Trading/CYCC/Form 4/A

Ferguson Kenneth M.

DirectorCyclacel Pharmaceuticals, Inc. (CYCC) · full profile →Form 4/A · filed Jun 17, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 14, 2022Grant(A)24K—$024K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 14, 2022Grant(A)47K—$047K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001104659-22-072381) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML